Objective: To determine the percentage of diabetic retinopathy and its associated risk factors among type 2 diabetic patients attending diabetes care clinic at Assiut university hospitals. Method: A cross sectional study was conducted between January to December 2014, including 204 type 2 diabetic patients attending diabetes care clinic at Assiut university hospitals to be screened for diabetic retinopathy and its associated risk factors. Results: Diabetic retinopathy(DR)was found in 24% of patients (16.7%, mild NPDR ,2.9% moderate NPDR , 3 .4% diabetic macular edema and 1% PDR ). Compared to those without retinopathy, longer duration of diabetes (11.3 ± 7.6 versus 5.9 ± 5.9 years; P<0.001), higher systolic blood pressure (121.8 ± 6.3versus 121.2 ± 5.9; P = 0.003), poor glycemic control (Hemoglobin A1C = 10.9 ± 1.7 versus 9.6 ± 1.8; P<0.001)and insulin therapy (P<0.001) were considered as a major risk factors for DR. Other risk factors include lower HDL (41.8 ± 28.3 versus 53.4 ± 36.4; P <0.001), higher level of total cholesterol, serum creatinine. Insulin therapy and high total cholesterol level were the most significant independent risk factors. Conclusion: Early screening, tight glycemic control, control of hypertension and dyslipidemia play an important role in the prevention of sight-threatening retinopathy. Also insulin treatment should be taken into consideration when managing a case of DR .
INTRODUCTION
Diabetic retinopathy (DR) is the leading cause of vision loss in adults aged 20-74 years [1] . From 1990-2010, DR ranked as the fifth most common cause of preventable blindness and fifth most common cause of moderate to severe visual impairment [2] Proliferative diabetic retinopathy (PDR) is the most common vision-threatening lesion particularly among patients with type 1 diabetes. However, diabetic macular edema (DME) is responsible for most of the visual loss experienced by patients with diabetes as it remains the major cause of vision loss in the highly prevalent type 2 diabetes [3] and is invariably present in patients with type 2 diabetes with PDR [4] . In addition to vision loss, DR and DME have also been shown to contribute to the development of other diabetes-related complications including nephropathy, peripheral neuropathy and cardiovascular events [5] . Early detection, control and treatment of diabetes itself will help in reduction in cases of diabetic retinopathy and to delay progression of non-proliferative diabetic retinopathy (NPDR) to PDR. The factors, which have a contribution in presence and progression of visual impairment, due to DR are modifiable (blood glucose, blood pressure, serum lipids, obesity, alcohol, and smoking), non-modifiable (duration, age, sex) [6] and other independent variables like type of diabetes mellitus, family history of DR. More focus should be towards modifiable risk factors. Long term protection is possible if blood glucose levels are controlled which reduces microvascular complications and progression of severity of DR [7] . Similarly, better blood pressure control in diabetic patients reduces progression of DR. Antihypertensive medication with renin-angiotensin system blockade helps in prevention of occurrence of DR in type 1and of its progression in type 2 DM [7] . Lowering of blood lipids is beneficial to diabetic maculopathy because it results in less retinal vessel leakage and hard exudate formation. National data regarding the percentage of diabetic retinopathy among type 2 diabetic patients, the severity of visual impairment occurred and major risk factors predisposing to its development in the Egyptian population are lacking. Therefore, this study was conducted.
PATIENTS AND METHODS
Sampling: Sample size was calculated considering the expected frequency of 40% as reported among Kuwaiti diabetic patients (8) 
Instruments and methods of Data Collection
Data were collected using structured interview questionnaires. The demographic information of each study subject including his/her name, age, sex, address was taken after obtaining informed consent. History containing study variables like duration of diabetes, current therapy intake either insulin or oral hypoglycemic medications, smoking status, and family history of diabetes was recorded. Complete clinical examination .Body mass index (BMI) was calculated as weight in kilogram divided by height in meter square [weight (Kg) / Height (m 2 )].Blood pressure of each subject was measured in right arm, supine position. Two readings were taken 30 minutes apart and the average of two was taken as a final reading. In our study the patients were considered hypertensive if their blood pressure >140/90 or who reported being on treatment for hypertension. The diagnosis of artery heart disease (CAD) was established if the patient had ECG proven coronary ischemia or history of acute coronary syndrome and or stable angina, coronary angioplasty or coronary artery by-pass grafting. Clinical neurological examination performed to assess the presence of peripheral polyneuropathy including pressure sensation detected by using 10g monofilament. Ophthalmic examination: Visual acuity was measured using Snellen's chart. A slit lamp was used for anterior segment evaluation. IOP measurement was performed by Goldman a planation tonometer. Indirect ophthalmoscopy was done after complete pupillary dilatation by 1% tropicamide eye drops. Classification of retinopathy was based on fundus examination findings of the worst eye of each subject. Laboratory investigations: Complete blood picture. Glycemic control was measured by Hemoglobin A1C (HbA1C). Complete lipid profile estimating of total serum cholesterol, high density lipoprotein, and serum triglycerides (TG). Renal function assessment by measurement of blood urea and serum creatinine levels was performed. 0.964 Multiple logistic regression analysis was performed to determine independent effects of associated risk factors on diabetic retinopathy. The results showed that the only significant independent factors associated with diabetic retinopathy are insulin as a type of treatment of diabetes and high total cholesterol level.
RESULT

DISCUSSION
The overall prevalence of DR observed in our study was (24%) and only (2.9%) has DME, which is concordant with the global documented data 2012 regarding the prevalence of DR in Egypt which was 20.5% (9, 10) Taking into consideration that patients attending our center in Assiut University tend to be an 0||August 1179 -11782 ||04||Issue||08||Page Vol R JMSC 6102 older population with a long duration of diabetes, poor diabetic control and lower socioeconomic status and this was a major motivation for us to undertake this work. When compared our results to that reported in middle east and north Africa region, we showed a lower prevalence of DR than those reported in Yemen 55%, Kuwait 40%, Saudi Arabia 34.6% and Jordan 64.1% (8, 9, 10) , and it is higher than that reported in Morocco 10%, Tunisia 18.3% and Bahrain 10%. (9, 10) This difference of prevalence could be explained by the fact that most of these studies were population based compared to our study which had smaller sample size and exclusion of type 1 DM. Also different tools were used for measurement. Regarding the grades of retinopathy , we found that the proportion of mild grade of retinopathy was higher than that reported from Kuwait, Saudi Arabia and a lower proportion of DME 2.9% sight threatening retinopathy than Kenya 33.3% and Kuwait 20.6% (11, 8) Our study found no significant gender difference in the development of DR, which is in accordance with multiple studies mostly from USA and Middle East (12) but in contrast other studies from India, and UAE observed to be more prevalent in male diabetics. (13, 14) Also a significant association between DR and duration of diabetes was observed which is consistent with most of the previous studies (10, 12) , while the age of the patient had no significant association. Hypertension especially systolic hypertension was considered as a risk factor for DR in this study, also the vascular damage caused by hypertension has an additive effect on the severity of DR. different previous studies from Jordan and Kuwait (8) revealed that DR is significantly associated with hypertension. While in contrast, a study in India (13) found no significant role of hypertension in the development of DR.
It is well known that hyperglycemia is one of the most important determinants of diabetic microvascular complications (15) , this was also observed in our study as patients with DR had higher mean HbA1c 10.9 ± 1.7 versus 9.6 ± 1.8 in patients without DR. A recent meta-analysis of case-control studies revealed that mean levels of serum TC, LDL-C, and TG were significantly higher in patients with DR and DME compared with those without DME and this is consistent with our results, as total cholesterol (TC) and serum low-density lipoprotein cholesterol (LDL-C) are associated with the presence of hard exudates in patients with DR (16) The effect obesity on DR has been relatively well-studied but with inconclusive and conflicting findings, a recent study reported that persons with higher body mass index and larger neck circumference were found more likely to have DR and more severe DR (17) , while BMI did not appear as significant risk factors as reported by the studies in UAE [14] which is consistent with our results. It was evident that Increasing severity of DR was associated with increasing severity of chronic kidney disease and decreased estimated glomerular filtration rate (18) ,and we showed that diabetic patients with diabetic retinopathy had significantly higher Serum Creatinine level(115.6 ± 76.8 versus 91.2 ± 44.6 mg/dl; P<0.05 ). Hence assessment of the renal parameters-blood urea, serum creatinine and microalbumuria, is important, especially if DR is present. DR in Type 2 diabetes is found to be associated with a 1.7-fold increased risk of cardiovascular events, such as stroke, coronary artery disease (CAD), and heart failure (19) , but in our study no significant association was observed between DR and CAD As regarding insulin treatment, we observed higher prevalence of DR among patients on insulin therapy compared to those on oral therapy, also insulin was found to be an independent risk factor for the development of DR,and this was also proved in two recent studies in Saudi Arabia (20) . 
LIMITATIONS
